Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats.
about
Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategiesMesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunitiesThe Vegetative State and Stem Cells: Therapeutic ConsiderationsGranulocyte colony-stimulating factor increases the therapeutic efficacy of bone marrow mononuclear cell transplantation in cerebral ischemia in mice.The effect of adipose tissue-derived stem cells in a middle cerebral artery occlusion stroke model depends on their engraftment rateComparative Therapeutic Effects of Minocycline Treatment and Bone Marrow Mononuclear Cell Transplantation following Striatal Stroke.Molecular and cellular immune responses to ischemic brain injuryMenstrual blood transplantation for ischemic stroke: Therapeutic mechanisms and practical issues.The isolation and cultivation of bone marrow stem cells and evaluation of differences for neural-like cells differentiation under the induction with neurotrophic factors.Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its MechanismsThe potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.Human umbilical cord blood cells alter blood and spleen cell populations after stroke.Acute splenic responses in patients with ischemic stroke and intracerebral hemorrhage.Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantationIntraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia.More insight into mesenchymal stem cells and their effects inside the body.Human umbilical cord blood stem cells: rational for use as a neuroprotectant in ischemic brain disease.Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke.Microglial responses after ischemic stroke and intracerebral hemorrhage.Intravascular stem cell transplantation for stroke.Bone marrow stromal cells as a therapeutic treatment for ischemic stroke.The splenic response to ischemic stroke: what have we learned from rodent models?Repeated administrations of human umbilical cord blood cells improve disease outcomes in a mouse model of Sanfilippo syndrome type III B.Stem cell-based therapies for ischemic stroke.Motor-evoked potential confirmation of functional improvement by transplanted bone marrow mesenchymal stem cell in the ischemic rat brain.Intra-arterial bone marrow mononuclear cell distribution in experimental global brain ischaemia.Minocycline treatment and bone marrow mononuclear cell transplantation after endothelin-1 induced striatal ischemia.Early transplantation of bone marrow mononuclear cells promotes neuroprotection and modulation of inflammation after status epilepticus in mice by paracrine mechanisms.Alternatively activated microglia co-cultured with BMSCS offers a new strategy in the treatment of CNS-associated disease.
P2860
Q26740083-7EBC0FF5-5004-43C3-BA0C-0F2D9224D70FQ26799013-19C42210-B38D-4B70-9973-E58CFF2103B6Q28066108-1C2F5083-88FD-489A-B754-AED4DAD96A4CQ31020646-00996FA5-5F49-4600-B7D7-21A1844036B9Q33608949-511F9EBD-0773-4E51-8FE1-4F8CFD06452CQ33872953-7D2167EE-6A01-42A1-A51B-7EFE9BFDAD5CQ34016804-8C58B7D3-60FE-47BB-97B9-446AB47D400EQ34253171-8B6B6CE2-72AE-4B9F-92E8-C7C3AD9829FAQ34534757-98381F1C-374B-4E8D-A6B6-BD999CBF10A4Q35663793-CEEC1202-1E29-47E7-8247-4391D9A57000Q36054671-B0701EF4-C4A9-4009-ACA0-1F896CC10BF0Q36540712-ED6EB2D2-7168-4342-9051-D0F283FF93E1Q37006243-885EA551-5569-4ACD-9325-D33E9F0103EEQ37125914-B718E412-4048-4E2F-A196-A21252A14651Q37587747-8549329C-813D-4DDD-BF5F-F0110DC858CFQ37678413-208373A5-A913-40A9-A216-61526F2B81DCQ37801289-356D0296-2751-4E3C-9D01-999CB7C26D00Q38086083-7023D813-57EE-4476-92DF-B791CD426F4CQ38139296-C5F22AC7-4D48-4C7D-8F6E-13F026DDA584Q38162224-4C19FC6F-8B6E-49AA-AFE3-070249B24B9DQ38170033-1FDC66EA-C45A-44C6-8333-C362215CAF81Q38210965-122427AA-3704-42B7-B28B-7488CC5473ABQ39712806-32CF90B4-F1A2-45E7-8DE9-958151A91E19Q41614431-C549BA2D-57CE-42C9-BA2C-DFF50A12F6BEQ41928171-1EB6B093-CE15-4449-97F9-7B785F33844DQ42795235-0678C042-9602-4E4E-94D7-B9C7A5FB2C33Q46121599-63689872-7EAA-4226-AE60-CE43B41A4F15Q48389920-E41DFAF8-9EB4-40DC-B086-4CCA370F8961Q50466351-530939A1-0DB8-4D58-8A58-CF62DAE857BBQ51049129-C244AE14-6015-47E3-A647-5909EEA169B1
P2860
Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Early transient presence of im ...... ebral ischaemia in adult rats.
@en
Early transient presence of im ...... ebral ischaemia in adult rats.
@nl
type
label
Early transient presence of im ...... ebral ischaemia in adult rats.
@en
Early transient presence of im ...... ebral ischaemia in adult rats.
@nl
prefLabel
Early transient presence of im ...... ebral ischaemia in adult rats.
@en
Early transient presence of im ...... ebral ischaemia in adult rats.
@nl
P2093
P1476
Early transient presence of im ...... ebral ischaemia in adult rats.
@en
P2093
E Keimpema
H W G M Boddeke
J C V M Copray
M R Fokkens
P G M Luiten
P2860
P304
P356
10.1111/J.1365-2990.2008.00961.X
P577
2009-02-01T00:00:00Z